STUDY OF CHRONIC ORAL ADMINISTRATION OF VERAPAMIL ON IMMUNOLOGIC AND HEMATOLOGIC PARAMETERS OF MALE RATS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SHABANI M.; ZAHEDIASL S.; MANAHEJI H.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Cell Journal (Yakhteh) Year:2004 | Volume:6 | Issue:22 Page(s): 65-68

Download Full-Text

Persian Verion

View:

919

Download:

Cites:

Information Journal Paper

Title

STUDY OF CHRONIC ORAL ADMINISTRATION OF VERAPAMIL ON IMMUNOLOGIC AND HEMATOLOGIC PARAMETERS OF MALE RATS

Author(s)

SHABANI M. | ZAHEDIASL S. | MANAHEJI H. | Issue Writer Certificate

Keywords

VERAPAMILQ3

LEUKOCYTESQ3

ERYTHROCYTESQ3

LYMPHOCYTEQ3

Abstract

Introduction: VERAPAMIL, a phenylalkylamin –type ca 2+ channel blocker, is widely used in the treatment of cardiovascular diseases . Material and Methods: In this study , the chronic effects of oral administration of the drug on hematologi and immunologic parameters of male Wistar rats have been studied. VERAPAMIL was administered orally at dosages of 10,20,50 mg/kg for two months, while control rats received only distilled water. We studied leukocyte and erythrocyte counts by use of light microscopy. Results: The LYMPHOCYTE counts were decreased (%10) in rats treated with 20,50 mg/kg of VERAPAMIL compared to control group. The monocyte counts were signifigantly increased (%5-8) at the end of treatment in the VERAPAMIL group. There were no significant differences in the body weight, total white and red blood cell counts ,and neutrophil count compared to control group. Conclusion: These results should be taken into consideration in the chronic treatment of patients with VERAPAMIL and they suggest that immune parameters of such patients should be monitored during the treatment course.

Cites

No record.

References

Cite

APA: Copy

SHABANI, M., ZAHEDIASL, S., & MANAHEJI, H.. (2004). STUDY OF CHRONIC ORAL ADMINISTRATION OF VERAPAMIL ON IMMUNOLOGIC AND HEMATOLOGIC PARAMETERS OF MALE RATS. CELL JOURNAL (YAKHTEH), 6(22), 65-68. SID. https://sid.ir/paper/16434/en

Vancouver: Copy

SHABANI M., ZAHEDIASL S., MANAHEJI H.. STUDY OF CHRONIC ORAL ADMINISTRATION OF VERAPAMIL ON IMMUNOLOGIC AND HEMATOLOGIC PARAMETERS OF MALE RATS. CELL JOURNAL (YAKHTEH)[Internet]. 2004;6(22):65-68. Available from: https://sid.ir/paper/16434/en

IEEE: Copy

M. SHABANI, S. ZAHEDIASL, and H. MANAHEJI, “STUDY OF CHRONIC ORAL ADMINISTRATION OF VERAPAMIL ON IMMUNOLOGIC AND HEMATOLOGIC PARAMETERS OF MALE RATS,” CELL JOURNAL (YAKHTEH), vol. 6, no. 22, pp. 65–68, 2004, [Online]. Available: https://sid.ir/paper/16434/en

Related Journal Papers